Relationships between plasma measures of oxidative stress and metabolic control in NIDDM

Diabetologia

Volumn 40, Issue 6, 1997, Pages 647-653

  Nourooz Zadeh, J ^a   Rahimi, A ^b   Tajaddini Sarmadi, J ^a   Tritschler, H ^c   Rosen, P ^d   Halliwell, B ^e   Betteridge, D J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ASTA MEDICA AG   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Lipid hydroperoxides; NIDDM; Oxidative stress; Vitamin E

Indexed keywords

ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDATIVE STRESS; REFERENCE VALUES; REGRESSION ANALYSIS; TRIGLYCERIDES; VITAMIN E;

EID: 0030743527     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050729     Document Type: Article

References (53)

1. Pyorala K, Laakso M, Uusitupa M (1987) Diabetes and atherosclerosis:an epidemiological view. Daibetes 3: 463-524
2. Kanell WB, Hjorland M, Castelli WP (1974) Role of diabetes in cardiac disease:conclusion from population studies. Am J Cardiol 34: 29-34
3. Uusittupa M, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K (1990) Five-years incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in NIDDM and non-diabetic subjects. Circulation 82: 27-36
4. Oberley LW (1988) Free radicals and diabetes. Free Radical Biol Med. 5: 113-124
5. Baynes JW (1991) Perspectives in diabetes: role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412
6. Wolff SP (1993) Diabetes and free radicals. In: Cheeseman KH, Slater TF (eds) Free radicals in medicine. British Medical Bulletin, Vol 49. Churchill Livingstone Edinburgh London Madrid Mellbourne New York Tokyo, pp 642-652
7. Giugliano D, Ceriello A, Paolisso G (1995) Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 44: 363-368
8. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: modification of LDL that increase atherogenicity. New Engl J Med 320: 915-924
9. Feingold KR, Grunfeld C, Pang M, Doerrler M, Krauss RM (1992) LDL subclass pheotypes and triglyceride metabolism in NIDDM. Arterioscler Throm 12: 1496-1502
10. Sobenin LA, Tertov VV, Koschinsky T et al. (1993) Modified LDL from diabetic patients causes cholesterol accumulation in human aortic cells. Atherosclerosis. 100: 41-54
11. Morel DW, Chisolm GM (1989) Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 30: 1827-1834
12. Lyons TJ (1991) Oxidised LDL: a role in the pathogenesis of atherosclerosis in diabetes? Diabet Med 8: 411-419
13. Halliwell B (1996) Oxidative stress, nutrition and health: Experimental strategies for optimization of nutritional antioxidants intakes in humans. Free Rad Biol Med 25: 57-74
14. Velazques E, Winocour PH, Kesteven P, Alberti KGMM, Laker MF (1991) Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med 8: 752-758
15. MacRury SM, Gordon D, Wilson R et al. (1993) A comparison of different methods of assessing free radical activity in type 2 diabetes and peripheral vascular disease. Diabet Med 10: 331-335
16. Griesmacher A, KinderHauser M, Andert S et al. (1995) Enhanced serum levels of TBARS in diabetes mellitus. Am J Med 98: 469-475
17. Niskanen LK, Salonen JT, Nyssonen K, Uusitupa MIJ (1995) Plasma lipid peroxidation and hyperglycaemia: a connection through hyperinsulinaemia. Diabet Med 12: 802-808
18. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanatthan M, Mohan R, Shanmugasundaram KR (1996) Antioxidant status and lipid peroxidation in type II diabetes with and without complications. Clin Sci 90: 255-260
19. Stringer MD, Gorog PG, Freeman A, Kakkar VV (1989) Lipid peroxides and atherosclerosis. BMJ 298: 281-284
20. Chirico S, Smith C, Marchant C, Mitchinson MJ, Halliwell B (1993) Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Radical Res Comm 19: 51-57
21. Thompson KH, Godin DV (1995) Micronutrients and antioxidants in the progression of diabetes. Nutr Res 15: 1377-1410
22. Tsai EC, Hirsch IB, Brunzell JD, Chait A (1994) Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43: 1010-1014
23. Asayama K, Uchida N, Nakane T et al. (1993) Antioxidants in the serum of children with IDDM. Free Radical Biol Med 15:597-602
24. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP (1995) Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 44: 1054-1058
25. Volk GD, Nauta JJP, Strijers, Bertelsmann FW (1986) Clinical versus neurophysiological examination in the diagnosis of diabetic polyneuropathy. Diabet Med 9: 716-721
26. Gatling W, Knight C, Mullee MA, Hill RD (1988) Microalbuminuria in diabetes: a population study of the prevelance and an assessment of the three screening tests. Diabet Med 5: 343-347
27. 1 by agar gel electrophoresis. Clin Chem 26: 1598-1602
28. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP (1994) Measurement of plasma hydroperoxide concentrations by the ferrous-oxidation in xylenol (FOX) assay in conjunction with triphenylphosphine. Anal Biochem 220: 403-409
29. Gey KF (1986) On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta 37: 53-91
30. Thomas SM, Jessup W, Gebicki JM, Dean RT (1989) A continuous-flow automated assay for iodometric estimation of hydroperoxides. Anal Biochem 176: 353-359
31. Cramer GL, Miller JF, Pendleton RB, Lands WEM (1991) Measurement of lipid hydroperoxides in human plasma. Anal Biochem 193: 204-211
32. Marshall PJ, Warso MA, Land WEM (1985) Selective microdetermination of lipid hydroperoxides. Anal Biochem 145: 192-199
33. Zamburlini A, Maiorino M, Barbera P et al. (1995) Measurement of lipid hydroperoxides in plasma by a new high-sensitive single photon counting luminometer. Biochem Biophys Acta 1256: 233-240
34. Zamburlini A, Maiorino M, Barbera P, Roveri A, Ursini F (1996) Direct measurement by single photon counting of lipid hydroperoxides in human plasma and lipoproteins. Anal Biochem 232: 107-113
35. Frei B, Yamamoto Y, Niclas D, Ames BN (1988) Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma. Anal Biochem 175: 120-130
36. Miyazawa T (1989) Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radical Biol Med 7: 209-217
37. Holley AE, Slater TR (1991) Measurement of lipid hydroperoxides in normal human blood plasma using HPLC-CL linked to a diode array detector for measuring conjugated dienes. Free Radical Res Commun 15: 51-63
38. Yamamoto Y, Brodsky MH, Baker JC, Ames BN (1987) Detection and characterisation of lipid hydroperoxides at picomole levels by HPLC. Anal Biochem 160: 7-13
39. Yamamotto Y, Niki E (1989) Presence of cholesteryl ester hydroperoxides in human blood plasma. Biochem Biophys Res Commun 165: 988-993
40. Coghlan JG, Flitter WD, Holley AE et al. (1991) Detection of free radicals and lipid hydroperoxides in blood taken from the coronary sinus of man during percutaneous transluminol coronary angioplasty. Free Radical Res Commun 14: 409-417
41. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett AH (1987) Increased diene conjugates in diabetic subjects with microangiopathy. Diabet Med 4: 452-456
42. 2α levels are elevated in individuals with NIDDM. FEBS Lett 368: 225-229
43. Yokota T, Tsuchiya K, Furukawa T, Tsukagoshi H, Miayakawa H, Hasumura Y (1990) Vitamin E deficiency in acquired fat malabsorption. J Neurol 237: 103-106
44. Martinoli L, Di-Felice M, Seghieri G et al. (1993) Plasma retinol and alpha-tocopherol concentrations in NIDDM. Int J Vitam Nutr Res. 63: 87-92
45. Singh RB, Ghosh S, Niaz MA et al. (1995) Dietary intake, plasma level of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in eldery subjects. Am J Cardiol 76: 1233-1238
46. Reaven PD, Herold DA, Barnett J, Edelman S (1995) Effects of vitamin E on susceptibility of LDL and LDL subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 18: 807-816
47. Reaven P (1995) Dietary and pharmacologic regimens to reduce lipid peroxidation in NIDDM. Am J Clin Nutr 62[Suppl]:1483-1493
48. Haffner SM, Agil A, Mykkanen L, Stern M, Jialal I (1995) Plasma oxidisability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM. Diabetes Care 18: 646-653
49. Karpen CW, Cataland S, O'Dorisio TM, Panganamala RV (1985) Production of 12-HETES and vitamin E status in platelets from type I human diabetic subjects. Diabetes 34: 526-531
50. Salonen JT, Nyyssonen K, Tuomainen TP et al. (1995) Increased risk of NIDDM at low vitamin E concentrations:a four year follow up study in men. BMJ 311: 1124-1127
51. Stampfer MJ, Hennekens CH, Manson JE, Coldtiz G, Rosener B, Willett WC (1993) Vitamin E consumption and the risk of coronary disease in women. New Engl J Med 328: 1444-1449
52. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz G, Willett WC (1993) Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med 328: 1450-1456
53. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson J, Brown MJ (1996) Radomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 347: 781-786